Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Personal care accountability

This article was originally published in The Tan Sheet

Executive Summary

Consumers of personal care products are increasingly growing more savvy and health-conscious, holding personal-care firms accountable for product ingredients and the health of communities in which they manufacture, according to Terry Burstein, interim chair of fashion at the Laboratory Institute of Merchandising in New York. Mirroring trends in the food market, consumers have become more interested in the natural/organic realm due largely to the work of consumer advocacy groups such as the Campaign for Safe Cosmetics. Natural marketers will likely be expected to back up formula claims and play a more visible role in educating consumers on what "natural" and "organic" mean, the executive notes. In July, a Natural Products Association work group announced plans to develop a standard definition for the term "natural" in personal care (1"The Tan Sheet" Aug. 20, 2007, p. 10)...

You may also be interested in...



Natural Dentist’s Rinse Highlights Challenges Of Defining “Natural”

This fall, The Natural Dentist's Healthy Gums Daily Oral Rinse will feature a new naturally derived ingredient to replace the sole artificial ingredient in its current formulation, according to CEO Nancy Rosenzweig

‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation

CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.

Biogen Sees Improving Momentum In Slow Leqembi Launch

Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS101162

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel